{"pmid":32374538,"title":"[Emergency department : COVID-19 crisis and organizational aspects].","text":["[Emergency department : COVID-19 crisis and organizational aspects].","Emergency departments are on the front line in the management of COVID-19 cases, from screening to the initial management of the most severe cases. The clinical presentation of COVID-19 range from non-specific symptoms to adult acute respiratory distress syndrome (ARDS). Diagnosis is based on PCR from a nasopharyngeal swab and emergency treatment rely on oxygen therapy. Patient's orientation (home, hospitalization, admission in intensive care unit) is a central aspect of emergency management. The shift from a strategy of systematic recognition of potential cases to the one of epidemic mitigation required hospital emergency medicine services to implement crisis management measures, to guarantee admission and hospitalization capacity.","Rev Med Suisse","Ageron, Francois-Xavier","Sarasin, Francois","Pasquier, Mathieu","Carron, Pierre-Nicolas","32374538"],"abstract":["Emergency departments are on the front line in the management of COVID-19 cases, from screening to the initial management of the most severe cases. The clinical presentation of COVID-19 range from non-specific symptoms to adult acute respiratory distress syndrome (ARDS). Diagnosis is based on PCR from a nasopharyngeal swab and emergency treatment rely on oxygen therapy. Patient's orientation (home, hospitalization, admission in intensive care unit) is a central aspect of emergency management. The shift from a strategy of systematic recognition of potential cases to the one of epidemic mitigation required hospital emergency medicine services to implement crisis management measures, to guarantee admission and hospitalization capacity."],"journal":"Rev Med Suisse","authors":["Ageron, Francois-Xavier","Sarasin, Francois","Pasquier, Mathieu","Carron, Pierre-Nicolas"],"date":"2020-05-07T11:00:00Z","year":2020,"_id":"32374538","source":"PubMed","week":"202019|May 04 - May 10","topics":["Prevention"],"weight":1,"_version_":1666138496394330114,"score":9.490897,"similar":[{"pmid":32348056,"title":"[Organizational Impacts and Clinical Challenges of the COVID-19 Pandemic on a Swiss Tertiary Internal Medicine Department].","text":["[Organizational Impacts and Clinical Challenges of the COVID-19 Pandemic on a Swiss Tertiary Internal Medicine Department].","The rapid progression of COVID-19 is an organizational challenge for all hospitals. To secure the patient overflow, the Department internal medicine of the University Hospital of Lausanne increased nurse and medical workforces as well as bed capacity by 65 %, with extraordinary help from other departments. The implemented crisis management stood upon three pillars : a crisis management team, steering documents and internal communication. In this new form, the Department had already taken care of 442 COVID-19 admissions by April 16, 2020. Alongside organizational challenges, clinical issues such as rapid respiratory distress, clinical suspicions with negative PCR and treatment uncertainties in the absence of sufficient evidence were overcome. Despite the peak of the pandemic appearing to have passed, the next phase could be just as complicated.","Rev Med Suisse","Garnier, Antoine","Vaucher, Julien","Bianchi, Christophe","Kraege, Vanessa","Mean, Marie","Castioni, Julien","Bart, Pierre-Alexandre","Champier, Valerie","Eggimann, Philippe","Gachoud, David","Jovanovic, Milica","Lamy, Olivier","Marques-Vidal, Pedro","Monti, Matteo","Perier, Anne","Robert, Sylvie","Roulet, Guillaume","Sartori, Claudio","Waeber, Gerard","Vollenweider, Peter","32348056"],"abstract":["The rapid progression of COVID-19 is an organizational challenge for all hospitals. To secure the patient overflow, the Department internal medicine of the University Hospital of Lausanne increased nurse and medical workforces as well as bed capacity by 65 %, with extraordinary help from other departments. The implemented crisis management stood upon three pillars : a crisis management team, steering documents and internal communication. In this new form, the Department had already taken care of 442 COVID-19 admissions by April 16, 2020. Alongside organizational challenges, clinical issues such as rapid respiratory distress, clinical suspicions with negative PCR and treatment uncertainties in the absence of sufficient evidence were overcome. Despite the peak of the pandemic appearing to have passed, the next phase could be just as complicated."],"journal":"Rev Med Suisse","authors":["Garnier, Antoine","Vaucher, Julien","Bianchi, Christophe","Kraege, Vanessa","Mean, Marie","Castioni, Julien","Bart, Pierre-Alexandre","Champier, Valerie","Eggimann, Philippe","Gachoud, David","Jovanovic, Milica","Lamy, Olivier","Marques-Vidal, Pedro","Monti, Matteo","Perier, Anne","Robert, Sylvie","Roulet, Guillaume","Sartori, Claudio","Waeber, Gerard","Vollenweider, Peter"],"date":"2020-04-30T11:00:00Z","year":2020,"_id":"32348056","source":"PubMed","week":"202018|Apr 27 - May 03","topics":["Prevention"],"weight":1,"_version_":1666138495375114240,"score":165.39072},{"pmid":32307151,"pmcid":"PMC7161530","title":"Clinical Consensus Recommendations Regarding Non-Invasive Respiratory Support in the Adult Patient with Acute Respiratory Failure Secondary to SARS-CoV-2 infection.","text":["Clinical Consensus Recommendations Regarding Non-Invasive Respiratory Support in the Adult Patient with Acute Respiratory Failure Secondary to SARS-CoV-2 infection.","Coronavirus disease 2019 (COVID-19) is a respiratory tract infection caused by a newly emergent coronavirus, that was first recognized in Wuhan, China, in December 2019. Currently, the World Health Organization (WHO) has defined the infection as a global pandemic and there is a health and social emergency for the management of this new infection. While most people with COVID-19 develop only mild or uncomplicated illness, approximately 14% develop severe disease that requires hospitalization and oxygen support, and 5% require admission to an intensive care unit. In severe cases, COVID-19 can be complicated by the acute respiratory distress syndrome (ARDS), sepsis and septic shock, and multiorgan failure. This consensus document has been prepared on evidence-informed guidelines developed by a multidisciplinary panel of health care providers from four Spanish scientific societies (Spanish Society of Intensive Care Medicine [SEMICYUC], Spanish Society of Pulmonologists [SEPAR], Spanish Society of Emergency [SEMES], Spanish Society of Anesthesiology, Reanimation, and Pain [SEDAR]) with experience in the clinical management of patients with COVID-19 and other viral infections, including SARS, as well as sepsis and ARDS. The document provides clinical recommendations for the noninvasive respiratory support (noninvasive ventilation, high flow oxygen therapy with nasal cannula) in any patient with suspected or confirmed presentation of COVID-19 with acute respiratory failure. This consensus guidance should serve as a foundation for optimized supportive care to ensure the best possible chance for survival and to allow for reliable comparison of investigational therapeutic interventions as part of randomized controlled trials.","Rev Esp Anestesiol Reanim","Cinesi Gomez, C","Penuelas Rodriguez, O","Lujan Torne, M L","Egea Santaolalla, C","Masa Jimenez, J F","Garcia Fernandez, J","Carratala Perales, J M","Heili-Frades, S B","Ferrer Monreal, M","de Andres Nilsson, J M","Lista Arias, E","Sanchez Rocamora, J L","Garrote, J I","Zamorano Serrano, M J","Gonzalez Martinez, M","Farrero Munoz, E","Mediano San Andres, O","Rialp Cervera, G","Mas Serra, A","Hernandez Martinez, G","de Haro Lopez, C","Roca Gas, O","Ferrer Roca, R","Romero Berrocal, A","Ferrando Ortola, C","32307151"],"abstract":["Coronavirus disease 2019 (COVID-19) is a respiratory tract infection caused by a newly emergent coronavirus, that was first recognized in Wuhan, China, in December 2019. Currently, the World Health Organization (WHO) has defined the infection as a global pandemic and there is a health and social emergency for the management of this new infection. While most people with COVID-19 develop only mild or uncomplicated illness, approximately 14% develop severe disease that requires hospitalization and oxygen support, and 5% require admission to an intensive care unit. In severe cases, COVID-19 can be complicated by the acute respiratory distress syndrome (ARDS), sepsis and septic shock, and multiorgan failure. This consensus document has been prepared on evidence-informed guidelines developed by a multidisciplinary panel of health care providers from four Spanish scientific societies (Spanish Society of Intensive Care Medicine [SEMICYUC], Spanish Society of Pulmonologists [SEPAR], Spanish Society of Emergency [SEMES], Spanish Society of Anesthesiology, Reanimation, and Pain [SEDAR]) with experience in the clinical management of patients with COVID-19 and other viral infections, including SARS, as well as sepsis and ARDS. The document provides clinical recommendations for the noninvasive respiratory support (noninvasive ventilation, high flow oxygen therapy with nasal cannula) in any patient with suspected or confirmed presentation of COVID-19 with acute respiratory failure. This consensus guidance should serve as a foundation for optimized supportive care to ensure the best possible chance for survival and to allow for reliable comparison of investigational therapeutic interventions as part of randomized controlled trials."],"journal":"Rev Esp Anestesiol Reanim","authors":["Cinesi Gomez, C","Penuelas Rodriguez, O","Lujan Torne, M L","Egea Santaolalla, C","Masa Jimenez, J F","Garcia Fernandez, J","Carratala Perales, J M","Heili-Frades, S B","Ferrer Monreal, M","de Andres Nilsson, J M","Lista Arias, E","Sanchez Rocamora, J L","Garrote, J I","Zamorano Serrano, M J","Gonzalez Martinez, M","Farrero Munoz, E","Mediano San Andres, O","Rialp Cervera, G","Mas Serra, A","Hernandez Martinez, G","de Haro Lopez, C","Roca Gas, O","Ferrer Roca, R","Romero Berrocal, A","Ferrando Ortola, C"],"date":"2020-04-21T11:00:00Z","year":2020,"_id":"32307151","source":"PubMed","week":"202017|Apr 20 - Apr 26","doi":"10.1016/j.redar.2020.03.006","keywords":["aerosol-generating procedures","control de infeccion.","high-flow nasal therapy","infection control","non-invasive mechanical ventilation","procedimientos generadores de aerosoles","terapia nasal de alto flujo","ventilacion mecanica no invasiva"],"locations":["Wuhan","China","multiorgan","Spanish","Spanish","Spanish","Spanish","Spanish"],"countries":["China","Spain"],"countries_codes":["CHN|China","ESP|Spain"],"topics":["Treatment"],"weight":1,"_version_":1666138491176615936,"score":132.10603},{"pmid":32312600,"title":"Clinical consensus recommendations regarding non-invasive respiratory support in the adult patient with acute respiratory failure secondary to SARS-CoV-2 infection.","text":["Clinical consensus recommendations regarding non-invasive respiratory support in the adult patient with acute respiratory failure secondary to SARS-CoV-2 infection.","Coronavirus disease 2019 (COVID-19) is a respiratory tract infection caused by a newly emergent coronavirus, that was first recognized in Wuhan, China, in December 2019. Currently, the World Health Organization (WHO) has defined the infection as a global pandemic and there is a health and social emergency for the management of this new infection. While most people with COVID-19 develop only mild or uncomplicated illness, approximately 14% develop severe disease that requires hospitalization and oxygen support, and 5% require admission to an intensive care unit. In severe cases, COVID-19 can be complicated by the acute respiratory distress syndrome (ARDS), sepsis and septic shock, and multiorgan failure. This consensus document has been prepared on evidence-informed guidelines developed by a multidisciplinary panel of health care providers from four Spanish scientific societies (Spanish Society of Intensive Care Medicine [SEMICYUC], Spanish Society of Pulmonologists [SEPAR], Spanish Society of Emergency [SEMES], Spanish Society of Anesthesiology, Reanimation, and Pain [SEDAR]) with experience in the clinical management of patients with COVID-19 and other viral infections, including SARS, as well as sepsis and ARDS. The document provides clinical recommendations for the noninvasive respiratory support (noninvasive ventilation, high flow oxygen therapy with nasal cannula) in any patient with suspected or confirmed presentation of COVID-19 with acute respiratory failure. This consensus guidance should serve as a foundation for optimized supportive care to ensure the best possible chance for survival and to allow for reliable comparison of investigational therapeutic interventions as part of randomized controlled trials.","Med Intensiva","Cinesi Gomez, Cesar","Penuelas Rodriguez, Oscar","Lujan Torne, Manel","Egea Santaolalla, Carlos","Masa Jimenez, Juan Fernando","Garcia Fernandez, Javier","Carratala Perales, Jose Manuel","Heili-Frades, Sarah Beatrice","Ferrer Monreal, Miquel","de Andres Nilsson, Jose M","Lista Arias, Eva","Sanchez Rocamora, Juan Luis","Garrote, Jose Ignacio","Zamorano Serrano, Miguel J","Gonzalez Martinez, Monica","Farrero Munoz, Eva","Mediano San Andres, Olga","Rialp Cervera, Gemma","Mas Serra, Arantxa","Hernandez Martinez, Gonzalo","de Haro Lopez, Candelaria","Roca Gas, Oriol","Ferrer Roca, Ricard","Romero Berrocal, Antonio","Ferrando Ortola, Carlos","32312600"],"abstract":["Coronavirus disease 2019 (COVID-19) is a respiratory tract infection caused by a newly emergent coronavirus, that was first recognized in Wuhan, China, in December 2019. Currently, the World Health Organization (WHO) has defined the infection as a global pandemic and there is a health and social emergency for the management of this new infection. While most people with COVID-19 develop only mild or uncomplicated illness, approximately 14% develop severe disease that requires hospitalization and oxygen support, and 5% require admission to an intensive care unit. In severe cases, COVID-19 can be complicated by the acute respiratory distress syndrome (ARDS), sepsis and septic shock, and multiorgan failure. This consensus document has been prepared on evidence-informed guidelines developed by a multidisciplinary panel of health care providers from four Spanish scientific societies (Spanish Society of Intensive Care Medicine [SEMICYUC], Spanish Society of Pulmonologists [SEPAR], Spanish Society of Emergency [SEMES], Spanish Society of Anesthesiology, Reanimation, and Pain [SEDAR]) with experience in the clinical management of patients with COVID-19 and other viral infections, including SARS, as well as sepsis and ARDS. The document provides clinical recommendations for the noninvasive respiratory support (noninvasive ventilation, high flow oxygen therapy with nasal cannula) in any patient with suspected or confirmed presentation of COVID-19 with acute respiratory failure. This consensus guidance should serve as a foundation for optimized supportive care to ensure the best possible chance for survival and to allow for reliable comparison of investigational therapeutic interventions as part of randomized controlled trials."],"journal":"Med Intensiva","authors":["Cinesi Gomez, Cesar","Penuelas Rodriguez, Oscar","Lujan Torne, Manel","Egea Santaolalla, Carlos","Masa Jimenez, Juan Fernando","Garcia Fernandez, Javier","Carratala Perales, Jose Manuel","Heili-Frades, Sarah Beatrice","Ferrer Monreal, Miquel","de Andres Nilsson, Jose M","Lista Arias, Eva","Sanchez Rocamora, Juan Luis","Garrote, Jose Ignacio","Zamorano Serrano, Miguel J","Gonzalez Martinez, Monica","Farrero Munoz, Eva","Mediano San Andres, Olga","Rialp Cervera, Gemma","Mas Serra, Arantxa","Hernandez Martinez, Gonzalo","de Haro Lopez, Candelaria","Roca Gas, Oriol","Ferrer Roca, Ricard","Romero Berrocal, Antonio","Ferrando Ortola, Carlos"],"date":"2020-04-22T11:00:00Z","year":2020,"_id":"32312600","source":"PubMed","week":"202017|Apr 20 - Apr 26","doi":"10.1016/j.medin.2020.03.005","keywords":["aerosol-generating procedures","control de infeccion","high-flow nasal therapy","infection control","non-invasive mechanical ventilation","procedimientos generadores de aerosoles","terapia nasal de alto flujo","ventilacion mecanica no invasiva"],"locations":["Wuhan","China","multiorgan","Spanish","Spanish","Spanish","Spanish","Spanish"],"countries":["China","Spain"],"countries_codes":["CHN|China","ESP|Spain"],"topics":["Treatment"],"weight":1,"_version_":1666138493449928705,"score":132.10603},{"pmid":32336563,"title":"Clinical Consensus Recommendations Regarding Non-Invasive Respiratory Support in the Adult Patient with Acute Respiratory Failure Secondary to SARS-CoV-2 infection.","text":["Clinical Consensus Recommendations Regarding Non-Invasive Respiratory Support in the Adult Patient with Acute Respiratory Failure Secondary to SARS-CoV-2 infection.","Coronavirus disease 2019 (COVID-19) is a respiratory tract infection caused by a newly emergent coronavirus, that was first recognized in Wuhan, China, in December 2019. Currently, the World Health Organization (WHO) has defined the infection as a global pandemic and there is a health and social emergency for the management of this new infection. While most people with COVID-19 develop only mild or uncomplicated illness, approximately 14% develop severe disease that requires hospitalization and oxygen support, and 5% require admission to an intensive care unit. In severe cases, COVID-19 can be complicated by the acute respiratory distress syndrome (ARDS), sepsis and septic shock, and multiorgan failure. This consensus document has been prepared on evidence-informed guidelines developed by a multidisciplinary panel of health care providers from four Spanish scientific societies (Spanish Society of Intensive Care Medicine [SEMICYUC], Spanish Society of Pulmonologists [SEPAR], Spanish Society of Emergency [SEMES], Spanish Society of Anesthesiology, Reanimation, and Pain [SEDAR]) with experience in the clinical management of patients with COVID-19 and other viral infections, including SARS, as well as sepsis and ARDS. The document provides clinical recommendations for the noninvasive respiratory support (noninvasive ventilation, high flow oxygen therapy with nasal cannula) in any patient with suspected or confirmed presentation of COVID-19 with acute respiratory failure. This consensus guidance should serve as a foundation for optimized supportive care to ensure the best possible chance for survival and to allow for reliable comparison of investigational therapeutic interventions as part of randomized controlled trials.","Arch Bronconeumol","Cinesi Gomez, Cesar","Penuelas Rodriguez, Oscar","Lujan Torne, Manel","Egea Santaolalla, Carlos","Masa Jimenez, Juan Fernando","Garcia Fernandez, Javier","Carratala Perales, Jose Manuel","Heili-Frades, Sarah Beatrice","Ferrer Monreal, Miquel","de Andres Nilsson, Jose M","Lista Arias, Eva","Sanchez Rocamora, Juan Luis","Garrote, Jose Ignacio","Zamorano Serrano, Miguel J","Gonzalez Martinez, Monica","Farrero Munoz, Eva","Mediano San Andres, Olga","Rialp Cervera, Gemma","Mas Serra, Arantxa","Hernandez Martinez, Gonzalo","de Haro Lopez, Candelaria","Roca Gas, Oriol","Ferrer Roca, Ricard","Romero Berrocal, Antonio","Ferrando Ortola, Carlos","32336563"],"abstract":["Coronavirus disease 2019 (COVID-19) is a respiratory tract infection caused by a newly emergent coronavirus, that was first recognized in Wuhan, China, in December 2019. Currently, the World Health Organization (WHO) has defined the infection as a global pandemic and there is a health and social emergency for the management of this new infection. While most people with COVID-19 develop only mild or uncomplicated illness, approximately 14% develop severe disease that requires hospitalization and oxygen support, and 5% require admission to an intensive care unit. In severe cases, COVID-19 can be complicated by the acute respiratory distress syndrome (ARDS), sepsis and septic shock, and multiorgan failure. This consensus document has been prepared on evidence-informed guidelines developed by a multidisciplinary panel of health care providers from four Spanish scientific societies (Spanish Society of Intensive Care Medicine [SEMICYUC], Spanish Society of Pulmonologists [SEPAR], Spanish Society of Emergency [SEMES], Spanish Society of Anesthesiology, Reanimation, and Pain [SEDAR]) with experience in the clinical management of patients with COVID-19 and other viral infections, including SARS, as well as sepsis and ARDS. The document provides clinical recommendations for the noninvasive respiratory support (noninvasive ventilation, high flow oxygen therapy with nasal cannula) in any patient with suspected or confirmed presentation of COVID-19 with acute respiratory failure. This consensus guidance should serve as a foundation for optimized supportive care to ensure the best possible chance for survival and to allow for reliable comparison of investigational therapeutic interventions as part of randomized controlled trials."],"journal":"Arch Bronconeumol","authors":["Cinesi Gomez, Cesar","Penuelas Rodriguez, Oscar","Lujan Torne, Manel","Egea Santaolalla, Carlos","Masa Jimenez, Juan Fernando","Garcia Fernandez, Javier","Carratala Perales, Jose Manuel","Heili-Frades, Sarah Beatrice","Ferrer Monreal, Miquel","de Andres Nilsson, Jose M","Lista Arias, Eva","Sanchez Rocamora, Juan Luis","Garrote, Jose Ignacio","Zamorano Serrano, Miguel J","Gonzalez Martinez, Monica","Farrero Munoz, Eva","Mediano San Andres, Olga","Rialp Cervera, Gemma","Mas Serra, Arantxa","Hernandez Martinez, Gonzalo","de Haro Lopez, Candelaria","Roca Gas, Oriol","Ferrer Roca, Ricard","Romero Berrocal, Antonio","Ferrando Ortola, Carlos"],"date":"2020-04-28T11:00:00Z","year":2020,"_id":"32336563","source":"PubMed","week":"202018|Apr 27 - May 03","doi":"10.1016/j.arbres.2020.03.005","keywords":["aerosol-generating procedures","control de infeccion","high-flow nasal therapy","infection control","non-invasive mechanical ventilation","procedimientos generadores de aerosoles","terapia nasal de alto flujo","ventilacion mecanica no invasiva"],"locations":["Wuhan","China","multiorgan","Spanish","Spanish","Spanish","Spanish","Spanish"],"countries":["China","Spain"],"countries_codes":["CHN|China","ESP|Spain"],"topics":["Treatment"],"weight":1,"_version_":1666138494176591872,"score":132.10603},{"pmid":32338347,"pmcid":"PMC7183927","title":"COVID-19 in Children: Clinical Approach and Management.","text":["COVID-19 in Children: Clinical Approach and Management.","COVID-19 pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a major public health crisis threatening humanity at this point in time. Transmission of the infection occurs by inhalation of infected droplets or direct contact with soiled surfaces and fomites. It should be suspected in all symptomatic children who have undertaken international travel in the last 14 d, all hospitalized children with severe acute respiratory illness, and asymptomatic direct and high-risk contacts of a confirmed case. Clinical symptoms are similar to any acute respiratory viral infection with less pronounced nasal symptoms. Disease seems to be milder in children, but situation appears to be changing. Infants and young children had relatively more severe illness than older children. The case fatality rate is low in children. Diagnosis can be confirmed by Reverse transcriptase - Polymerase chain reaction (RT-PCR) on respiratory specimen (commonly nasopharyngeal and oropharyngeal swab). Rapid progress is being made to develop rapid diagnostic tests, which will help ramp up the capacity to test and also reduce the time to getting test results. Management is mainly supportive care. In severe pneumonia and critically ill children, trial of hydroxychloroquine or lopinavir/ritonavir should be considered. As per current policy, children with mild disease also need to be hospitalized; if this is not feasible, these children may be managed on ambulatory basis with strict home isolation. Pneumonia, severe disease and critical illness require admission and aggressive management for acute lung injury and shock and/or multiorgan dysfunction, if present. An early intubation is preferred over non-invasive ventilation or heated, humidified, high flow nasal cannula oxygen, as these may generate aerosols increasing the risk of infection in health care personnel. To prevent post discharge dissemination of infection, home isolation for 1-2 wk may be advised. As of now, no vaccine or specific chemotherapeutic agents are approved for children.","Indian J Pediatr","Sankar, Jhuma","Dhochak, Nitin","Kabra, S K","Lodha, Rakesh","32338347"],"abstract":["COVID-19 pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a major public health crisis threatening humanity at this point in time. Transmission of the infection occurs by inhalation of infected droplets or direct contact with soiled surfaces and fomites. It should be suspected in all symptomatic children who have undertaken international travel in the last 14 d, all hospitalized children with severe acute respiratory illness, and asymptomatic direct and high-risk contacts of a confirmed case. Clinical symptoms are similar to any acute respiratory viral infection with less pronounced nasal symptoms. Disease seems to be milder in children, but situation appears to be changing. Infants and young children had relatively more severe illness than older children. The case fatality rate is low in children. Diagnosis can be confirmed by Reverse transcriptase - Polymerase chain reaction (RT-PCR) on respiratory specimen (commonly nasopharyngeal and oropharyngeal swab). Rapid progress is being made to develop rapid diagnostic tests, which will help ramp up the capacity to test and also reduce the time to getting test results. Management is mainly supportive care. In severe pneumonia and critically ill children, trial of hydroxychloroquine or lopinavir/ritonavir should be considered. As per current policy, children with mild disease also need to be hospitalized; if this is not feasible, these children may be managed on ambulatory basis with strict home isolation. Pneumonia, severe disease and critical illness require admission and aggressive management for acute lung injury and shock and/or multiorgan dysfunction, if present. An early intubation is preferred over non-invasive ventilation or heated, humidified, high flow nasal cannula oxygen, as these may generate aerosols increasing the risk of infection in health care personnel. To prevent post discharge dissemination of infection, home isolation for 1-2 wk may be advised. As of now, no vaccine or specific chemotherapeutic agents are approved for children."],"journal":"Indian J Pediatr","authors":["Sankar, Jhuma","Dhochak, Nitin","Kabra, S K","Lodha, Rakesh"],"date":"2020-04-28T11:00:00Z","year":2020,"_id":"32338347","source":"PubMed","week":"202018|Apr 27 - May 03","doi":"10.1007/s12098-020-03292-1","keywords":["ards","acute lung injury","acute respiratory distress syndrome","covid-19","hydroxychloroquine","lopinavir","multiorgan dysfunction","ritonavir","sars-cov-2","severe pneumonia"],"e_drugs":["Hydroxychloroquine","lopinavir-ritonavir drug combination"],"topics":["Prevention","Diagnosis","Transmission","Treatment"],"weight":1,"_version_":1666138494216437760,"score":130.1097}]}